XML 81 R66.htm IDEA: XBRL DOCUMENT
v3.24.1.u1

Salaries and other employee expenses (Tables) | 12 Months Ended
--- | ---
Dec. 31, 2023
Salaries and other employee expenses |
Schedule of salaries and other employee expenses | The following table details salaries and other employee expenses:
| December 31,
| 2023 |  | 2022 |  | 2021
Wages and salaries | 20,837 |  |  | 18,135 |  |  | 13,803 |
Payroll taxes | 2,809 |  |  | 2,196 |  |  | 1,731 |
Personnel benefits | 19,047 |  |  | 12,344 |  |  | 5,134 |
Share-based payments | 4,539 |  |  | 1,544 |  |  | 984 |
Total | 47,232 |  |  | 34,219 |  |  | 21,652 |
Schedule of restricted stock granted to directors | A summary of restricted stock granted to directors is presented below:
| Shares |  | Weighted average grant date fair value
Outstanding at January 1, 2021 | 132,150 |  |  | 18.56 |
Granted | 63,000 |  |  | 14.65 |
Vested | (49,350) |  |  | 19.24 |
Outstanding at December 31, 2021 | 145,800 |  |  | 16.64 |
Granted | 57,000 |  |  | 14.65 |
Vested | (97,350) |  |  | 18.71 |
Outstanding at December 31, 2022 | 105,450 |  |  | 14.15 |
Granted | 63,000 |  |  | 17.69 |
Vested | (53,100) |  |  | 13.75 |
Outstanding at December 31, 2023 | 115,350 |  |  | 16.31 |
Expected to vest | 115,350 |  |  |
Schedule of restricted stock units granted to certain executives | A summary of the restricted stock units granted through December 31, 2023, to certain executives is presented below:
| Shares |  | Weighted average grant date fair value |  | Weighted average remaining contractual term |  | Aggregate intrinsic value
Outstanding at January 1, 2021 | 81,343 |  |  | 17.94 |  |  |  |  |
Granted | 75,796 |  |  | 13.33 |  |  |  |  |
Forfeited | (1,311) |  |  | 14.51 |  |  |  |  |
Vested | (48,299) |  |  | 17.35 |  |  |  |  |
Outstanding at December 31, 2021 | 107,529 |  |  | 14.99 |  |  |  |  |
Granted | 63,056 |  |  | 13.03 |  |  |  |  |
Vested | (36,410) |  |  | 15.97 |  |  |  |  |
Outstanding at December 31, 2022 | 134,175 |  |  | 13.80 |  |  |  |  |
Granted | 298,951 |  |  | 15.36 |  |  |  |  |
Forfeited | (346) |  |  | 14.95 |  |  |  |  |
Vested | (152,305) |  |  | 15.57 |  |  |  |  |
Outstanding at December 31, 2023 | 280,475 |  |  | 14.50 |  |  | 1.99 years |  | $2,769
Expected to vest | 280,475 |  |  | 14.50 |  |  | 1.99 years |  | $2,769

X
- Definition The information about restricted stock options to directors. + References No definition available. + Details
Name: | blx_DisclosureOfDetailedInformationAboutRestrictedStockOptionToDirectorsTextBlock
Namespace Prefix: | blx_
Data Type: | dtr-types1:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | blx_DisclosureOfEmployeeBenefitsAbstract
Namespace Prefix: | blx_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for employee benefits. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Name IAS -Number 19 -IssueDate 2023-01-01 -Section Scope -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=19&code=ifrs-tx-2023-en-r&doctype=Standard&dita_xref=IAS19_g2-7_TI -URIDate 2023-03-23 + Details
Name: | ifrs-full_DisclosureOfEmployeeBenefitsExplanatory
Namespace Prefix: | ifrs-full_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition The disclosure of the number and weighted average exercise prices of other equity instruments (ie other than share options). + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Name IFRS -Number 2 -IssueDate 2023-01-01 -Paragraph 45 -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2023-en-r&anchor=para_45&doctype=Standard -URIDate 2023-03-23 + Details
Name: | ifrs-full_DisclosureOfNumberAndWeightedAverageExercisePricesOfOtherEquityInstrumentsExplanatory
Namespace Prefix: | ifrs-full_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration